Data as of Apr 17
| -0.19 / -2.73%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +47.71% increase from the last price of 6.77.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.